Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
干细胞结构驱动骨髓增生异常综合征进展并预测对维奈克拉治疗的反应
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-022-01696-4
Irene Ganan-Gomez, Hui Yang, Feiyang Ma, Guillermo Montalban-Bravo, Natthakan Thongon, Valentina Marchica, Guillaume Richard-Carpentier, Kelly Chien, Ganiraju Manyam, Feng Wang, Ana Alfonso, Shuaitong Chen, Caleb Class, Rashmi Kanagal-Shamanna, Justin P Ingram, Yamini Ogoti, Ashley Rose, Sanam Logha